219 related articles for article (PubMed ID: 23171852)
1. Effects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: a propensity score analysis.
Jung B; Clavieras N; Nougaret S; Molinari N; Roquilly A; Cisse M; Carr J; Chanques G; Asehnoune K; Jaber S
Crit Care; 2012 Nov; 16(6):R224. PubMed ID: 23171852
[TBL] [Abstract][Full Text] [Related]
2. Etomidate for intubation of patients who have sepsis or septic shock--where do we go from here?
Griesdale DE
Crit Care; 2012 Dec; 16(6):189. PubMed ID: 23273139
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of etomidate in severe sepsis and septic shock.
Dmello D; Taylor S; O'Brien J; Matuschak GM
Chest; 2010 Dec; 138(6):1327-32. PubMed ID: 20651024
[TBL] [Abstract][Full Text] [Related]
4. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database.
McPhee LC; Badawi O; Fraser GL; Lerwick PA; Riker RR; Zuckerman IH; Franey C; Seder DB
Crit Care Med; 2013 Mar; 41(3):774-83. PubMed ID: 23318491
[TBL] [Abstract][Full Text] [Related]
5. Etomidate and mortality in cirrhotic patients with septic shock.
Cherfan AJ; Tamim HM; AlJumah A; Rishu AH; Al-Abdulkareem A; Al Knawy BA; Hajeer A; Tamimi W; Brits R; Arabi YM
BMC Clin Pharmacol; 2011 Dec; 11():22. PubMed ID: 22208901
[TBL] [Abstract][Full Text] [Related]
6. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock.
Cuthbertson BH; Sprung CL; Annane D; Chevret S; Garfield M; Goodman S; Laterre PF; Vincent JL; Freivogel K; Reinhart K; Singer M; Payen D; Weiss YG
Intensive Care Med; 2009 Nov; 35(11):1868-76. PubMed ID: 19652948
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for mortality in septic patients who received etomidate.
Rech MA; Bennett S; Chaney W; Sterk E
Am J Emerg Med; 2015 Oct; 33(10):1340-3. PubMed ID: 26321168
[TBL] [Abstract][Full Text] [Related]
8. Relative adrenal insufficiency in etomidate-naïve patients with septic shock.
Jones D; Hayes M; Webb S; French C; Bellomo R
Anaesth Intensive Care; 2006 Oct; 34(5):599-605. PubMed ID: 17061634
[TBL] [Abstract][Full Text] [Related]
9. Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?: a critical appraisal.
Jackson WL
Chest; 2005 Mar; 127(3):1031-8. PubMed ID: 15764790
[TBL] [Abstract][Full Text] [Related]
10. [Etomidate can not be recommended to patients with septic shock].
Toft P; Jensen AG
Ugeskr Laeger; 2011 May; 173(20):1421-3. PubMed ID: 21586246
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial.
Payen JF; Dupuis C; Trouve-Buisson T; Vinclair M; Broux C; Bouzat P; Genty C; Monneret D; Faure P; Chabre O; Bosson JL
Crit Care Med; 2012 Jan; 40(1):29-35. PubMed ID: 21926601
[TBL] [Abstract][Full Text] [Related]
12. Clinical controversies: etomidate as an induction agent for endotracheal intubation in patients with sepsis: continue to use etomidate for intubation of patients with septic shock.
Walls RM; Murphy MF
Ann Emerg Med; 2008 Jul; 52(1):13-4. PubMed ID: 18565378
[No Abstract] [Full Text] [Related]
13. Outcome after intubation for septic shock with respiratory distress and hemodynamic compromise: an observational study.
Yang T; Shen Y; Park JG; Schulte PJ; Hanson AC; Herasevich V; Dong Y; Bauer PR
BMC Anesthesiol; 2021 Oct; 21(1):253. PubMed ID: 34696738
[TBL] [Abstract][Full Text] [Related]
14. Etomidate should be used carefully for emergent endotracheal intubation in patients with septic shock.
Kim TY; Rhee JE; Kim KS; Cha WC; Suh GJ; Jung SK
J Korean Med Sci; 2008 Dec; 23(6):988-91. PubMed ID: 19119441
[TBL] [Abstract][Full Text] [Related]
15. Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality.
den Brinker M; Joosten KF; Liem O; de Jong FH; Hop WC; Hazelzet JA; van Dijk M; Hokken-Koelega AC
J Clin Endocrinol Metab; 2005 Sep; 90(9):5110-7. PubMed ID: 15985474
[TBL] [Abstract][Full Text] [Related]
16. Increased incidence of clinical hypotension with etomidate compared to ketamine for intubation in septic patients: A propensity matched analysis.
Van Berkel MA; Exline MC; Cape KM; Ryder LP; Phillips G; Ali NA; Doepker BA
J Crit Care; 2017 Apr; 38():209-214. PubMed ID: 27974285
[TBL] [Abstract][Full Text] [Related]
17. In patients with severe sepsis, does a single dose of etomidate to facilitate intubation increase mortality?
Hunter BR; Kirschner J
Ann Emerg Med; 2013 May; 61(5):571-2. PubMed ID: 23465303
[TBL] [Abstract][Full Text] [Related]
18. Etomidate as an induction agent for endotracheal intubation in patients with sepsis.
Mittal MK
Ann Emerg Med; 2009 Mar; 53(3):405; author reply 406. PubMed ID: 19231675
[No Abstract] [Full Text] [Related]
19. Etomidate use in severe sepsis and septic shock patients does not contribute to mortality.
Ehrman R; Wira C; Lomax A; Hayward A; Marcelin J; Ellis T; Przyklenk K; Volturo G; Mullen M
Intern Emerg Med; 2011 Jun; 6(3):253-7. PubMed ID: 21394520
[TBL] [Abstract][Full Text] [Related]
20. Etomidate: not worth the risk in septic patients.
Sacchetti A
Ann Emerg Med; 2008 Jul; 52(1):14-6. PubMed ID: 18565379
[No Abstract] [Full Text] [Related]
[Next] [New Search]
